Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Momenta’s Generic Lovenox Suit Is Harbinger Of Biosimilar Battles Over Manufacturing

07 Nov 2011

• By Brenda Sandburg

Related Content

Sanofi's Lovenox Authorized Generic Could Help Speed Amphastar's Path To Market

25 Oct 2011

Generic <i>Lovenox</i> Battle Heats Up With Amphastar’s ANDA Approval

26 Sep 2011

FDA Approves Momenta/Sandoz' Lovenox Generic Without Need For Clinical Studies

23 Jul 2010

Related Companies

Amphastar Pharmaceuticals, Inc.

Allergan plc

Novartis AG

Novartis AG

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.